# ScoreItem: Delta Metano (Œî CH‚ÇÑ)

**ID:** `c77cedd3-2800-72d0-bc41-2d9516ec2bef`
**FullName:** Delta Metano (Œî CH‚ÇÑ) (Exames - Imagem)
**Unit:** ppm

**Preparation Metadata:**
- Quality Grade: **EXCELLENT**
- Total Chunks: 30 de 10 artigos
- Avg Similarity: 0.669

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `c77cedd3-2800-72d0-bc41-2d9516ec2bef`.**

```json
{
  "score_item_id": "c77cedd3-2800-72d0-bc41-2d9516ec2bef",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto cl√≠nico: 1-9 pts
- Alto impacto cl√≠nico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Crit√©rios: gravidade/mortalidade (40%), preval√™ncia (30%), intervencionabilidade (30%)

---

### Contexto Cient√≠fico

**ScoreItem:** Delta Metano (Œî CH‚ÇÑ) (Exames - Imagem)
**Unidade:** ppm

**30 chunks de 10 artigos (avg similarity: 0.669)**

### Chunk 1/30
**Article:** Understanding Our Tests: Hydrogen-Methane Breath Testing to Diagnose Small Intestinal Bacterial Overgrowth (2023)
**Journal:** Clinical and Translational Gastroenterology
**Section:** abstract | **Similarity:** 0.782

Revis√£o detalhada sobre testes respirat√≥rios hidrog√™nio-metano para diagn√≥stico de SIBO/IMO. Introduz o conceito de supercrescimento de metan√≥genos intestinais (IMO) para distinguir padr√µes predominantes em metano do SIBO cl√°ssico. M√∫ltiplos estudos identificaram que n√≠veis elevados de metano est√£o positivamente associados √† constipa√ß√£o, com o metano demonstrando inibir diretamente o tr√¢nsito intestinal em 59% em modelos animais. Um n√≠vel de metano ‚â•10 ppm em jejum ou em qualquer momento durante o teste define IMO positivo. Abordagem simplificada com medi√ß√£o √∫nica de metano em jejum (SMM) ‚â•10 ppm demonstrou alta performance diagn√≥stica compar√°vel aos protocolos padr√£o de 2 horas.

---

### Chunk 2/30
**Article:** S√≠ndrome do Intestino Irrit√°vel sob o olhar da Medicina Funcional Integrativa III (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.759

rat√≥rio para SIBO/IMO:** Considerado o m√©todo pr√°tico padr√£o, utilizando lactulose ou glicose.
    -   **Crit√©rio para SIBO (Hidrog√™nio):** Eleva√ß√£o acima de 20 ppm nos primeiros 90 minutos.
    -   **Crit√©rio para IMO (Metano):** Eleva√ß√£o acima de 10 ppm em qualquer momento do teste.
-   **Diagn√≥stico de SIFO:** O padr√£o ouro √© o aspirado duodenal com cultura (>10¬≥ UFC/ml de fungos), mas √© raramente realizado. A avalia√ß√£o da micobiota e metab√≥litos f√∫ngicos pode ser √∫til.
-   **Outros Achados:** Ativa√ß√£o do eixo HPA e rea√ß√£o de "die-off" (com manifesta√ß√µes cut√¢neas) durante tratamento antif√∫ngico.
## Diagn√≥stico Prim√°rio:
-   **Avalia√ß√£o:** O texto √© uma discuss√£o abrangente sobre a S√≠ndrome do Intestino Irrit√°vel (SII), suas causas subjacentes (aumento da permeabilidade intestinal, disbiose, inflama√ß√£o) e comorbidades como dist√∫rbios do sono, SIBO, IMO e SIFO.

---

### Chunk 3/30
**Article:** Methane on breath testing is associated with constipation: a systematic review and meta-analysis (2011)
**Journal:** Digestive Diseases and Sciences
**Section:** abstract | **Similarity:** 0.719

Revis√£o sistem√°tica e meta-an√°lise demonstrando associa√ß√£o significativa entre metano no teste respirat√≥rio e constipa√ß√£o. Encontrou raz√£o de chances (OR) de 3,51 (IC 95%: 2,00-6,16) para a associa√ß√£o entre metano e constipa√ß√£o. Os autores concluem que um fen√≥tipo cl√≠nico diferente est√° associado a n√≠veis mais elevados de produ√ß√£o de metano (constipa√ß√£o) em compara√ß√£o √† produ√ß√£o de hidrog√™nio (tipicamente diarreia). A constipa√ß√£o est√° associada a n√≠veis elevados de metano expirado e Methanobrevibacter smithii nas fezes, e o direcionamento terap√™utico aos metan√≥genos pode reduzir a produ√ß√£o de metano e melhorar a constipa√ß√£o.

---

### Chunk 4/30
**Article:** Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus (2017)
**Journal:** American Journal of Gastroenterology
**Section:** abstract | **Similarity:** 0.719

Este consenso norte-americano estabelece diretrizes para testes respirat√≥rios com hidrog√™nio e metano em dist√∫rbios gastrointestinais. Define que n√≠veis de metano ‚â•10 ppm devem ser considerados positivos, estabelecendo a correla√ß√£o entre metano e constipa√ß√£o. Pacientes com supercrescimento bacteriano predominante em metano t√™m 5 vezes mais probabilidade de apresentar constipa√ß√£o comparado aos casos predominantes em hidrog√™nio, com a gravidade correlacionando-se diretamente aos n√≠veis de metano.

---

### Chunk 5/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** results | **Similarity:** 0.710

s also include the small intestine. These results have important conse-quences. First, they reinforce the importance of breath testing and its interpretation. Excessive methane and meth-anogens are associated with constipation and the absence of excessive  CH4 allows the determination that higher  H2S producers mean looser stool. More importantly, identify-ing the organisms responsible for these gases, their precise gut locations, and their consequences for human health will help develop a new generation of approaches for treat-ing SIBO, IMO and sulÔ¨Åde overproduction.Supplementary Information The online version contains supplemen-tary material available at https:// doi. org/ 10. 1007/ s10620- 025- 09156-y.Acknowledgments The authors thank the REIMAGINE Study Group for their assistance in obtaining samples.

---

### Chunk 6/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** discussion | **Similarity:** 0.704

symptoms [14], is still evolving. Here, we show that breath  CH4 and  H2S levels are in fact inÔ¨Çuenced by small bowel microbial composi-tion. Enhanced understanding of diÔ¨Äerent types of microbial overgrowth and potential competition for gas utilization will improve how we interpret breath testing.Methane is an important gas in breath testing. Substantial evidence now suggests that  CH4 produced in the gut alters gut neuromuscular function [6] and is associated with con-stipation [7
]. Further, constipation severity is proportional to 

3853Digestive Diseases and Sciences (2025) 70:3846‚Äì3856 
breath  CH4 levels [38] and stool M. smithii levels. In a rand-omized-controlled study, reducing  CH4 with a combination of antibiotics improved constipation [8, 39]. Recently, stool microbiome analysis in IBS-C subjects found direct corre-lations between breath  
CH4, constipation, and M. smithii levels [11].

---

### Chunk 7/30
**Article:** S√≠ndrome do Intestino Irrit√°vel sob o olhar da Medicina Funcional Integrativa III (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.695

baixo de 100 ¬µg/g s√£o altamente sugestivos de SII.
*   **Avalia√ß√£o para Doen√ßa Cel√≠aca**
    - √â fundamental em todos os pacientes, n√£o apenas naqueles com diarreia. Inclui a dosagem de IgA s√©rica total e o anticorpo antitransglutaminase IgA.
*   **Avalia√ß√£o da Microbiota e Metabol√¥mica**
    - A metabol√¥mica (avalia√ß√£o dos produtos da microbiota) √© considerada mais importante que a an√°lise da microbiota isolada. A an√°lise de √°cidos org√¢nicos urin√°rios √© uma ferramenta √∫til.
    - A dosagem de zonulina pode ser um bom marcador para o aumento da permeabilidade intestinal.
*   **Supercrescimento Bacteriano do Intestino Delgado (SIBO)**
    - Incid√™ncia 3,7 vezes maior em portadores de SII. O diagn√≥stico pr√°tico √© feito pelo teste respirat√≥rio com lactulose ou glicose.
*   **Supercrescimento Metanog√™nico Intestinal (IMO)**
    - Supercrescimento de arqueias produtoras de metano, associado principalmente √† constipa√ß√£o intestinal.

---

### Chunk 8/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** discussion | **Similarity:** 0.691

hensive review. Gastroenterol Hepatol (N Y). 2007;3:112¬ñ122. 4. Rangan V, Nee J, Lembo AJ. Small intestinal bacterial overgrowth breath testing in gastroenterology: clinical utility and pitfalls. Clin Gastroenterol Hepatol. 2022;20:1450¬ñ1453. 5. Miller TL, Wolin MJ. Enumeration of Methanobrevibacter smithii in human feces. Arch Microbiol. 1982;131:14¬ñ18.

3855Digestive Diseases and Sciences (2025) 70:3846‚Äì3856 
 6. Pimentel M, Lin HC, Enayati P etal. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intes-tinal contractile activity. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1089-1095. 7. Kunkel D, Basseri RJ, Makhani MD, Chong K, Chang C, Pimentel M. Methane on breath testing is associated with constipation: a systematic review and meta-analysis. Dig Dis Sci. 2011;56:1612¬ñ1618 https:// doi. org/ 10. 1007/ s10620- 011- 1590-5. 8. Mehravar S, Takakura W, Wang J, Pimentel M, Nasser J, Rezaie A.

---

### Chunk 9/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** discussion | **Similarity:** 0.682

= 0.316, P = 0.001), Halar-chaeum sp. CBA1220 (R = 0.200, P = 0.037), and Candida-tus Nitrosotenuis cloacae (R = 0.201, P = 0.036). In IMO-negative subjects, P. mirabilis (R = 0.281, P = 0.021) and D. oligotrophicus (R = 0.353, P = 0.003) RAs correlated with looser stool.DiscussionHere, we demonstrate that  
CH4 levels on breath testing (BT) exhibit correlations with levels of methanogens in the small intestine. Importantly, the predominant methanogen M. smithii and other methanogens are present in the small intestine and appear to play additive roles in contributing to breath  CH4 levels, in addition to contributions from colonic methanogens. We also show that  H2S levels on BT exhibit correlations with levels of  
H2S-producing bacteria in the small intestine, including speciÔ¨Åcally P. mirabilis, D. oligo-trophicus, and D. widdelii.

---

### Chunk 10/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** other | **Similarity:** 0.675

ces (2025) 70:3846‚Äì3856 
by methanogenic archaea[5], in delayed gastrointestinal (GI) transit and constipation, including constipation-predominant irritable bowel syndrome (IBS-C) [6¬ñ9]; increased intesti-nal colonization with methanogens is now known as intes-tinal methanogen overgrowth (IMO) [10, 11]. Neither  H2 nor  CH4 are produced by human cells, so measuring these gases provides exclusive indirect markers of gut microbial composition. Adopting BT for the diagnosis of SIBO has facilitated an ever-increasing understanding of the role of SIBO in conditions such as irritable bowel syndrome (IBS) [12], celiac disease [13], and others.Recently, a third gas, hydrogen sulÔ¨Åde  (H2S) has been introduced to BT [14].  H2S is a gasotransmitter that plays important roles in inÔ¨Çammation and mucosal repair in the GI tract [15] and has been linked to diarrhea-predominant irritable bowel syndrome (IBS-D) [16, 17].

---

### Chunk 11/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** discussion | **Similarity:** 0.675

analysis in IBS-C subjects found direct corre-lations between breath  
CH4, constipation, and M. smithii levels [11]. Moreover, a recent consensus now recognizes  CH4 as a contributor to constipation in IBS-C [40]. How-ever, studies of  
CH4 on BT to date, including microbiome studies, have utilized stool. Here, we conÔ¨Årm that, as previ-ously shown [41], M. smithii and other methanogens also colonize the small intestine and that the duodenal archaeal proÔ¨Åle of subjects with IMO is signiÔ¨Åcantly diÔ¨Äerent from that in non-IMO subjects, with an almost threefold increase in the relative abundance (RA) of the entire Methanobacte-riaceae family in the duodenum of IMO subjects. Further, we demonstrate relationships between breath  CH4 levels and the duodenal RAs of M. smithii and other archaea includ-ing Halarchaeum sp. CBA1220, Desulfurococcus muco-sus, and Halobaculum rubrum. Lastly, the RAs of both M. smithii and Halarchaeum sp.

---

### Chunk 12/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** discussion | **Similarity:** 0.665

-analysis. Dig Dis Sci. 2011;56:1612¬ñ1618 https:// doi. org/ 10. 1007/ s10620- 011- 1590-5. 8. Mehravar S, Takakura W, Wang J, Pimentel M, Nasser J, Rezaie A. Symptom ProÔ¨Åle of Patients With Intestinal Methanogen Over-growth: A Systematic Review and Meta-analysis. Clin Gastroen-terol Hepatol. 2024;23:1111-1122.e9. 9. Ghoshal U, Shukla R, Srivastava D, Ghoshal UC. Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase in Methanobrevibacter smithii, Which Is Associated with Higher Methane Production. Gut Liver. 2016;10:932¬ñ938. 
10. Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gas-troenterol. 2020;115:165¬ñ178. 
11. Villanueva-Millan MJ, Leite G, Wang J etal. Methanogens and Hydrogen SulÔ¨Åde Producing Bacteria Guide Distinct Gut Microbe ProÔ¨Åles and Irritable Bowel Syndrome Subtypes. Am J Gastroenterol. 2022;117:2055¬ñ2066. 
12. Shah A, Talley NJ, Jones M etal.

---

### Chunk 13/30
**Article:** S√≠ndrome do Intestino Irrit√°vel sob o olhar da Medicina Funcional Integrativa III (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.662

m Estudo Low FODMAP: 12 meses (per√≠odo de acompanhamento).
**Biomarcadores fecais e testes respirat√≥rios orientam a diferencia√ß√£o entre SII e doen√ßa org√¢nica, e a detec√ß√£o de SIBO/SIFO.**
- Ponto de Corte Inferior de Calprotectina (fecal): 100 (ponto de corte inferior para avalia√ß√£o de SII).
- Probabilidade de SII com Calprotectina <100: 98% (alta probabilidade de diagn√≥stico funcional).
- Faixa de Zona Cinzenta da Calprotectina: 100‚Äì250 (necessita interpreta√ß√£o cautelosa).
- Limite de Calprotectina para Colonoscopia: 250 (exige colonoscopia).
- Crit√©rio Diagn√≥stico de SIBO por Aspirado: 10^3 UFC/ml (crit√©rio diagn√≥stico via aspirado).
- Crit√©rio de Positividade no Teste Respirat√≥rio de Hidrog√™nio: >20 partes por milh√£o em at√© 90 minutos (positividade de H2).
- Crit√©rio de Positividade no Teste Respirat√≥rio de Metano: >10 partes por milh√£o em qualquer momento (positividade de CH4).

---

### Chunk 14/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** methods | **Similarity:** 0.660

mirabilis, D. oligo-trophicus, and D. widdelii. These data support the concept that breath gas proÔ¨Åles are inÔ¨Çuenced, at least in part, by small bowel microbial composition.Over the last half century, SIBO and BT have been increasingly understood. Despite the long history of BT as an indirect technique for assessing SIBO, and more recently IMO, the methodology to validate BT was not available until recently. An important question was whether BT Ô¨Åndings were related to the levels of microorganisms producing these gases. The lack of data supported criticisms of BT, such as suggestions that BT, and particularly lactulose BT, is merely a marker of transit [36, 37]. Moreover, the measurement of breath  H2S, and the understanding that overgrowth of  H2S producers may contribute to patient symptoms [14], is still evolving. Here, we show that breath  CH4 and  H2S levels are in fact inÔ¨Çuenced by small bowel microbial composi-tion.

---

### Chunk 15/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** other | **Similarity:** 0.658

be assessed by breath testing in a large clinical cohort.Interestingly, there appears to be an overlap in coloniza-tion of subjects with methanogens and  H2S producers and the manifestation of stool phenotypes. Looseness of stool appears to only occur in the presence of  H2S producers and absence of methanogens. Constipation is the dominant fea-ture any time methanogens result in a  CH4 level  10ppm (i.e., IMO). Below this point,  H2S producers correlate with looser stool. It is, however, important to note that in this study only the small bowel is being assessed. There is a likely possibility that colonic production of both  CH4 and  H2S further compound gas production and levels on breath test, as well as phenotypes.It is notable to Ô¨Ånd methanogens in the small intestine as the small intestine is often recognized as a higher oxygen portion of the gut that should not allow for the growth of strict anaerobes such as methanogens.

---

### Chunk 16/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** other | **Similarity:** 0.656

studies identiÔ¨Åed SIBO by culturing small bowel aspirates [2, 3]. Subsequently, breath testing (BT) became an estab-lished indirect technique for diagnosing SIBO based on levels of hydrogen  (H2) on the breath [4]. Originally, BT onlymeasured  H2, but later testing also incorporated meas-urement of methane  (CH4). This allowed researchers to elu-cidate the importance of  CH4, which is produced in the gut 
 * Mark Pimentel  pimentelm@cshs.org1 Medically Associated Science andTechnology (MAST) Program, Cedars-Sinai, 770 N.

---

### Chunk 17/30
**Article:** Pros and Cons of Breath Testing for Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth (2023)
**Journal:** Gastroenterology & Hepatology
**Section:** abstract | **Similarity:** 0.652

This review examines diagnostic breath testing for SIBO and IMO, highlighting its advantages as a safe, noninvasive, widely accessible test that distinguishes hydrogen-predominant SIBO from IMO for tailored antibiotic therapy. Limitations include indirect measurement of microbial overgrowth, variability in orocecal transit time, risk of false-positive and false-negative results, and requirement for strict patient protocol compliance.

---

### Chunk 18/30
**Article:** S√≠ndrome do Intestino Irrit√°vel sob o olhar da Medicina Funcional Integrativa III (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.650

ose.
*   **Supercrescimento Metanog√™nico Intestinal (IMO)**
    - Supercrescimento de arqueias produtoras de metano, associado principalmente √† constipa√ß√£o intestinal.
*   **Supercrescimento F√∫ngico (SIFO) e a Micobiota**
    - Altera√ß√µes na comunidade f√∫ngica podem ocorrer mesmo com microbiota bacteriana normal. O sintoma mais frequente √© o "blurring" (sensa√ß√£o de estar distendido). A avalia√ß√£o da metabol√¥mica pode ser mais √∫til que exames de PCR.
### 3. Estrat√©gias de Tratamento e Otimiza√ß√£o Digestiva
*   **Parceria M√©dico-Nutricionista**
    - A colabora√ß√£o √© fundamental para o sucesso do tratamento, especialmente na implementa√ß√£o de dietas como a Low FODMAP.
*   **Otimiza√ß√£o do Processo Digest√≥rio**
    - √â crucial avaliar e otimizar a digest√£o antes de outras interven√ß√µes. A abordagem funcional envolve retirar excessos ou acrescentar o que falta (ex: acidez, enzimas).

---

### Chunk 19/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** conclusion | **Similarity:** 0.649

ccurrence of all 4 species (P = 0.04). In IMO-positive subjects,  CH4 levels correlated with greater constipation severity (P = 0.019); P. mirabilis (P = 0.021) and D. oligotrophicus (P = 0.003) correlated with looser stool in IMO-negative subjects. M. smithii prevalence correlated with known hydrogen-producing syntrophs, e.g., Christensenella minuta (P < 0.001).Conclusion This study demonstrates that duodenal prevalences of  H2S-producing bacteria and methanogenic archaea con-tribute to  
H2S and  
CH4 levels, respectively, on BT.Keywords Breath testing¬∑ Duodenum¬∑ Microbiome¬∑ Methane¬∑ Hydrogen sulÔ¨Åde¬∑ Methanobrevibacter smithii¬∑ Proteus mirabilisIntroductionSmall intestinal bacterial overgrowth (SIBO) has been rec-ognized as a clinical condition for half a century [1]. Early studies identiÔ¨Åed SIBO by culturing small bowel aspirates [2, 3].

---

### Chunk 20/30
**Article:** ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth (2020)
**Journal:** American Journal of Gastroenterology
**Section:** abstract | **Similarity:** 0.641

This ACG clinical guideline provides evidence-based recommendations for diagnosing and managing SIBO. Glucose and lactulose breath tests are recommended diagnostic tools, with interpretation based on consensus criteria. A rise in hydrogen ‚â•20 ppm from baseline within 90 minutes (glucose) or 90-120 minutes (lactulose) is considered positive. The guideline emphasizes the importance of proper test preparation, including dietary restrictions and medication avoidance, to minimize false-positive and false-negative results.

---

### Chunk 21/30
**Article:** Reevaluating our understanding of lactulose breath tests by incorporating hydrogen sulfide measurements (2019)
**Journal:** JGH Open: An Open Access Journal of Gastroenterology and Hepatology
**Section:** discussion | **Similarity:** 0.640

ig.Dis.Sci.1998;43:2080‚Äì5.16LevittMD.Productionandexcretionofhydrogengasinman.N.Engl.J.Med.1969;281:122‚Äì7.17YuD,CheesemanF,VannerS.Combinedoro-caecalscintigraphyandlactulosehydrogenbreathtestingdemonstratethatbreathtestingdetectsoro-caecaltransit,notsmallintestinalbacterialovergrowthinpatientswithIBS.Gut.2011;60:334‚Äì40.18KajsTM,FitzgeraldJA,BucknerRYetal.InuenceofamethanogenicoraonthebreathH2andsymptomresponsetoingestionofsorbitoloroatber.Am.J.Gastroenterol.1997;92:89‚Äì94.19NingY,LouC,HuangZetal.Clinicalvalueofradionuclidesmallintestinetransittimemeasurementcombinedwithlactulosehydrogenbreathtestforthediagnosisofbacterialovergrowthinirritablebowel
syndrome.Hell.J.Nucl.Med.2016;19:124‚Äì9.20KokuboT,MatsuiS,IshiguroM.Meta-analysisoforo-cecaltransittimeinfastingsubjects.Pharm.Res.2013;30:402‚Äì11.21LinHC,PratherC,FisherRSetal.Measurementofgastrointestinaltransit.Dig.Dis.Sci.2005;50:989‚Äì1004.22ScarpelliniE,AbenavoliL,BalsanoC,GabrielliM,LuzzaF,TackJ.Breathtestsfortheassessmento

---

### Chunk 22/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** other | **Similarity:** 0.640

smithii in the duodenum (Supplemental Fig.10), but there were no direct correlations between the RAs of any of these species. Breath  CH4 levels increased signiÔ¨Åcantly with co-occurrence of two (P = 0.018), three (P = 0.027), or four (P = 0.008) of these methanogens, as compared to none (Fig.4A). A positive BT for IMO  (CH4  10ppm) was also more common when all four of these species co-occurred (P = 0.04) (Fig.4B). Furthermore, breath  
CH4 levels in IMO-positive subjects correlated with constipa-tion severity (R = 0.577, P = 0.019).CH4 Producers Correlated withKnown  H2-Producing Bacterial Syntrophs intheDuodenumThe bacterial families Christensenellaceae and Rumino-coccaceae include known  H2-producing syntrophs for methanogens [31¬ñ34]. Consistent with this, positive corre-lations were found between RAs of bacterial species from these families and the archaeal species that correlated with breath  CH4. M.

---

### Chunk 23/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** other | **Similarity:** 0.640

odesulfobacteriota. Higher breath  H2S levels correlated with greater duode-nal prevalences of  
H2S producers, including Proteus mirabilis (P = 0.002), Desulfosarcina widdelii (P = 0.027), and Desulfob-ulbus oligotrophicus (P = 0.041); co-occurrence of all 3 species correlated with ~ 50% higher breath  H2S levels (P = 0.0001). Duodenal archaeal proÔ¨Åles diÔ¨Äered signiÔ¨Åcantly in subjects with intestinal methanogen overgrowth (IMO,  CH4  10ppm), with 2.94-log2fold greater prevalence of family Methanobacteriaceae vs. non-IMOsubjects. Higher breath  CH4 correlated with greater prevalences of methanogens including M. smithii (P = 0.02), Halarchaeum sp. CBA1220 (P = 0.003), Desulfuro-coccus mucosus (P = 0.046), and Halobaculum rubrum (P = 0.049). IMO was more common in subjects with co-occurrence of all 4 species (P = 0.04). In IMO-positive subjects,  CH4 levels correlated with greater constipation severity (P = 0.019); P. mirabilis (P = 0.021) and D.

---

### Chunk 24/30
**Article:** S√≠ndrome do Intestino Irrit√°vel sob o olhar da Medicina Funcional Integrativa III (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.639

√©rio de Positividade no Teste Respirat√≥rio de Metano: >10 partes por milh√£o em qualquer momento (positividade de CH4).
- Preval√™ncia de SIBO em Pacientes com SII: 78% (positividade em estudo de 2000).
- Risco Relativo de SIBO em SII: 3,7 vezes (incid√™ncia maior em SII).
- Crit√©rio Diagn√≥stico de SIFO: 10^3 UFC/ml (crit√©rio diagn√≥stico para SIFO).
**Terapias complementares e neuromodula√ß√£o apoiam o controle de sintomas e comorbidades (sono, dor), especialmente quando h√° disbiose mic√≥tica ou hipersensibilidade.**
- Dura√ß√£o do Curso de Fluconazol para SIFO: duas a tr√™s semanas (curso antif√∫ngico).
- Taxa de Resposta a Antif√∫ngicos: 100% (resposta a fluconazol ou caspofungina).
- Posologia de Saccharomyces boulardii: 250 mg, duas vezes ao dia (adjuvante probi√≥tico).
- Dose Inicial de Pregabalina: 200/50 miligramas (doses iniciais referidas).
- Tempo de Estimula√ß√£o do Nervo Vago em Cada Orelha: 10 minutos (tempo na orelha direita e esquerda).

---

### Chunk 25/30
**Article:** Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens (2025)
**Journal:** Digestive Diseases and Sciences
**Section:** discussion | **Similarity:** 0.639

al RA of P. vulgaris  (log2FC:2.24, FDR P value = 1.31E‚àí3) and P. mirabilis when compared to subjects with breath  H2S < 1.5ppm  
(log2FC:1.17, FDR P value = 0.10, Supplemental Table3).CH4 Producers intheDuodenum Correlated with 
CH4 onBreath TestThe duodenal archaeal profile of subjects with IMO appeared to diÔ¨Äer from subjects without IMO (Supplemental Fig.7) and trended toward clustering together on a principal component analysis of beta-diversity (P = 0.08, Supplemen-tal Fig.8). The RA of the entire Methanobacteriaceae family was 2.94-log2 fold increased in the duodenum of IMO sub-jects when compared to non-IMO subjects (P value = 1.29E-3, FDR P value = 0.07).The predominant methanogen, M. smithii, was present in the duodenum of 63.64% of subjects and M. smithii RA correlated with breath  CH4 levels (R = 0.221, P = 0.02). RA of eight other archaeal species [27¬ñ30] also correlated with breath  CH4 (Table2, Supplemental Fig.9). Three of these, Halarchaeum sp.

---

### Chunk 26/30
**Article:** Functional Disease, Dysbiosis, and Dyspepsia: How Helpful Is Rifaximin? (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.639

t meta-analysis showed the prevalence of SIBO in FD was 2.8 times higher than in con-trols [4]. The prevalence of SIBO is higher in patients with overlap compared to isolated FD and IBS. The conventional diagnosis of SIBO is based on jejunal aspirate culture, with colony count   105CFU/ml diagnostic of SIBO. Non-inva-sive tests for diagnosis of SIBO used primarily in clinical practice are the glucose hydrogen breath test (GHBT) and lactulose hydrogen breath test (LHBT) [5]. Though popular, their accuracy is doubtful, with a recent meta-analysis show-ing both tests to have low sensitivity with high speciÔ¨Åcity. Rifaximin is the one of Ô¨Årst-choice therapies in SIBO, where it acts as a poorly absorbed oral antibiotic that alters the composition of the gut microbiota. This eÔ¨Äect is also use-ful in patients with IBS and FD where disturbances in gut microbial composition are common.

---

### Chunk 27/30
**Article:** Reevaluating our understanding of lactulose breath tests by incorporating hydrogen sulfide measurements (2019)
**Journal:** JGH Open: An Open Access Journal of Gastroenterology and Hepatology
**Section:** results | **Similarity:** 0.637

-
rently,hydrogenandmethanegasconcentrationsaremeasuredinbreathtestingand
evaluatedagainstspeciccut-offvaluesforinterpretationasnormalorabnormal.However,microbialgaskineticsisacomplexprocessthatisnotcurrentlyfullycon-
sideredwheninterpretingbreathgasresults.Gasexchangebetweenhydrogenpro-
ducersandhydrogenconsumers(methanogensandsulfate-reducingbacteria)isa
processwherebyhydrogenavailabilityisdeterminedbybothitsproductionand
removal.Hydrogensuldeisacrucialgasinvolvedinthisprocessasitisamajorhydrogen-consumptivepathwayinvolvedinenergyexchange.
Methods:Thisisacross-sectionalstudyevaluatinglactulosebreathtestingwiththeinclusionofhydrogensuldemeasurementsinpatientsreferredforbreathtestingforgastrointestinalsymptomsofbloating,excessivegas,and/orabdominalpain.

---

### Chunk 28/30
**Article:** Symptom Profile of Patients With Intestinal Methanogen Overgrowth: A Systematic Review and Meta-analysis (2025)
**Journal:** Clinical Gastroenterology and Hepatology
**Section:** abstract | **Similarity:** 0.630

This meta-analysis examined gastrointestinal symptoms in 1,293 patients with intestinal methanogen overgrowth (IMO) versus 3,208 controls across 19 studies. IMO patients demonstrated distinctive symptom patterns with bloating (78%), constipation (51%), and significantly elevated constipation rates (47% vs. 38% in controls) with increased severity, alongside reduced prevalence and severity of diarrhea.

---

### Chunk 29/30
**Article:** Reevaluating our understanding of lactulose breath tests by incorporating hydrogen sulfide measurements (2019)
**Journal:** JGH Open: An Open Access Journal of Gastroenterology and Hepatology
**Section:** other | **Similarity:** 0.628

iStefanoM,MengoliC,BergonziMetal.Breathmethaneexcre-tionisnotanaccuratemarkerofcolonicmethaneproductioninirrita-
blebowelsyndrome.Am.J.Gastroenterol.2015;110:891‚Äì8.3NakamuraN,LinHC,McSweeneyCS,MackieRI,GaskinsHR.Mechanismsofmicrobialhydrogendisposalinthehumancolonandimplicationsforhealthanddisease.Annu.Rev.FoodSci.Technol.2010;1:363‚Äì95.4ZhaoJ,ZhengX,ChuHetal.Astudyofthemethodologicalandclinicalvalidityofthecombinedlactulosehydrogenbreathtestwithscintigraphicoro-cecaltransittestfordiagnosingsmallintestinalbac-terialovergrowthinIBSpatients.Neurogastroenterol.Motil.2014;26:794‚Äì802.ReevaluatinglactulosebreathtestsABirgetal.232JGHOpen:Anopenaccessjournalofgastroenterologyandhepatology3(2019)228‚Äì233¬©2019TheAuthors.JGHOpen:AnopenaccessjournalofgastroenterologyandhepatologypublishedbyJournalofGastroenterologyandHepatologyFoundationandJohnWiley&SonsAustralia,Ltd.

---

### Chunk 30/30
**Article:** Reevaluating our understanding of lactulose breath tests by incorporating hydrogen sulfide measurements (2019)
**Journal:** JGH Open: An Open Access Journal of Gastroenterology and Hepatology
**Section:** results | **Similarity:** 0.627

etween
hydrogenproductionandconsumptionbymethanogenesisorsul-
fatereduction.Scintigraphiccecalarrivalcouldindicatethe
arrivaloftheheadoflactulosebolusintothececum.However,
breathhydrogenwouldonlyrisewhenhydrogenproductionhas
exceededthehydrogenconsumptiveprocesses.Thus,thetimeto
riseforbreathhydrogenwouldalwaysbelaterintimethanscin-
tigraphiccecalentry.InastudybyYuetal.,orocecalscintigraphywascom-paredtoLBTresults;theseauthorsfoundthat,inamajorityof
cases,timetoriseofbreathhydrogenoccurredaftercecalarrival
byscintigraphy.17Thisstudyconcludedthat,giventhetemporalrelationshipbetweenscintigraphyandbreathtesting,LBTwasnotreliableforthediagnosisofSIBO.17Thisdiscrepancycouldbeexplainedbytheworkofhydrogen-consumingmicrobes.As
hydrogengasisrapidlyusedupbyhydrogenconsumersin
methanogenesisorsulfatereduction,the‚Äúdelayed‚Äùtimetoriseofbreathhydrogen,whencomparedtoscintigraphiccecalarrival,
Figure4Graphicalrepresentationoflactulosebreathtestingresultsforpatientsconsidered‚Äúhydrogennonproducers 

---

